Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Lacutamab |
Trade Name | |
Synonyms | IPH-4102|IPH 4102|IPH4102 |
Drug Descriptions |
Lacutamab (IPH4102) is a monoclonal antibody that targets KIR3DL2, which potentially results in increased anti-tumor immune response against KIR3DL2-expressing tumor cells, and reduced tumor growth (PMID: 25361998, PMID: 31253572). |
DrugClasses | |
CAS Registry Number | 2187368-16-5 |
NCIT ID | C124999 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Gemcitabine + Lacutamab + Oxaliplatin | Gemcitabine Lacutamab Oxaliplatin | 0 | 2 |
Lacutamab | Lacutamab | 0 | 2 |